MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Co-Diagnostics ROE Ratio 2011-2026 | CODX
Annual ROE Ratio Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -227.33 | -69.86 | -41.08 | -12.43 | 27.26 | 63.69 | -356.63 | 592.34 | -180.73 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 592.34 | -356.63 | -22.75 |
Quarterly ROE Ratio Co-Diagnostics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -64.49 | -64.91 | -56.62 | -37.58 | -43.6 | -34.41 | -32.53 | -19.84 | -20.85 | -15.84 | -9.08 | 5.06 | 16.52 | 28.99 | 42.06 | 33.03 | 56.62 | 68.74 | 80.03 | 44.49 | -56.12 | -180.31 | -280.19 | -256.76 | -101.76 | 153.84 | 360.83 | 408.34 | 307.22 | 51.11 | -100.69 | -141.65 | -126.62 | -10.48 | 26.5 | 29.81 | 29.81 | 14.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 408.34 | -280.19 | 2.72 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 117.5 | 2.1 % | $ 35.7 B |  USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 16.83 | 4.86 % | $ 897 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | -4.35 % | $ 9.73 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 23.53 | 1.73 % | $ 654 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 178.34 | 1.53 % | $ 8.84 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.59 | 5.52 % | $ 425 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 501.23 | 1.56 % | $ 14.5 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.0 | 4.03 % | $ 1.02 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 195.87 | 3.3 % | $ 140 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 126.96 | 4.99 % | $ 20.2 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.3 | 6.03 % | $ 463 M | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.72 | 0.6 % | $ 280 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 82.21 | 4.59 % | $ 10.3 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.85 | 5.95 % | $ 92.5 K | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.08 | -2.8 % | $ 4.78 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.55 | 0.87 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 110.37 | 3.33 % | $ 9.1 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.64 | 0.02 % | $ 2.68 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 264.18 | 1.25 % | $ 22 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 201.9 | 4.6 % | $ 19.9 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 120.4 | 2.78 % | $ 5.63 B | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.39 | 2.96 % | $ 91.7 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 81.67 | 1.34 % | $ 5.51 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 192.91 | 0.73 % | $ 21.4 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.14 | -2.97 % | $ 1.98 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 5.19 | 5.06 % | $ 4.08 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |